Loading your page…
Marketing-authorisation holder
7 medicines in 2 countries, as authorisation holder and marketer.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CLONAZEPAM TZF 0,5 MG COMPRIMIDOS EFG0,5 mg · Comprimido | Clonazepam | Spain | Authorised | 2023 |
| Clonazepam TZF 0,5 mg, tablettenTablet | Clonazepam | Netherlands | Authorised | 2022 |
| CLONAZEPAM TZF 2 MG COMPRIMIDOS EFG2 mg · Comprimido | Clonazepam | Spain | Authorised | 2023 |
| Clonazepam TZF 2 mg, tablettenTablet | Clonazepam | Netherlands | Authorised | 2022 |
| Lorazepam TZF 0,5 mg, tablettenTablet | Lorazepam | Netherlands | Authorised | 2025 |
| Lorazepam TZF 1 mg, tablettenTablet | Lorazepam | Netherlands | Authorised | 2025 |
| Lorazepam TZF 2,5 mg, tablettenTablet | Lorazepam | Netherlands | Authorised | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 5 | 5 | 0 | CompaniesAll medicines |
| Spain | 2 | 2 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
